SEC Form 4 · accession 0001225208-19-000771
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — EVP,Pres MedSurg
Period of report
Jan 8, 2019
Accepted (ET)
Jan 9, 2019 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2019 | M | 5,000 | $7.16 | A | 39,520 | D | |
| Common Stock | Jan 8, 2019 | S | 5,000 | $35.00 | D | 34,520 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $7.16 | Jan 8, 2019 | M | 5,000 | D | — | Feb 28, 2021 | Common Stock | 5,000 | 22,640 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Grant to the reporting person of an option to purchase a specified number of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant.